Cognitive impairment and depression in patients with relapsing–remitting multiple sclerosis depending on age and neuroimaging findings

No Thumbnail Available

Date

2021-09-08

Journal Title

Journal ISSN

Volume Title

Publisher

Springer Nature

Abstract

Background: Multiple sclerosis is an insidious, disabling, both physically and mentally, demyelinating disease of the central nervous system. This work aims to evaluate relationships between cognitive impairment in separate domains, depression and their correspondence with MRI-fndings, as well as the infuence on each other’s manifestations, in patients with relapsing–remitting multiple sclerosis. Results: Visual–spatial/executive functions and memory domains sufered more frequently than others in the study subjects under 40 years; in patients over 40 years old memory, visual–spatial/executive functions and abstract thinking impairment prevailed the most. Such cognitive domains as memory, language, abstract thinking, visual–spatial and executive functions were impacted in both groups of patients even without the apparent cognitive decline according to MoCA scale. Presence of depression impacted language and attention more prominently than the rest of the domains only in participants younger 40 years. According to the MRI, frontal lobe, corpus callosum and periventricular area were afected more often compared to other brain regions in case of cognitive impairment; meanwhile, combined lesions of frontal lobe and corpus callosum, fronto-temporal region were associated with depression. Conclusion: Cognitive impairment and depression are one of the common, yet disabling and socially disrupting manifestations of MS. Quite frequently such complaints are neglected or considered as parts of comorbidities. At the same time cognitive impairment can be amplifed by depression, especially in patients under 40 years.

Description

Keywords

Multiple sclerosis, Cognitive impairment, Depression, MRI

Citation

Kopchak, O.O., Odintsova, T.A. Cognitive impairment and depression in patients with relapsing–remitting multiple sclerosis depending on age and neuroimaging findings. Egypt J Neurol Psychiatry Neurosurg 57, 119 (2021). https://doi.org/10.1186/s41983-021-00376-3